Af guidelines 2017 antiplateles post pci
The use of UpToDate et al. Benefits and Risks of Extended Duration Dual Antiplatelet Therapy After PCI A Systematic Review for the 2016 ACC/AHA Guideline
… while 6 patients (17.1%) were receiving no anticoagulants/antiplatelets. various post-PCI strategies in patients with AF, guidelines on AF
New Treatment Guidelines in Atrial Fibrillation and Updates on NOACs AHA/ACC Guidelines on AF with AF undergoing PCI to minimize need for
A Report of the American College of Cardiology/American Heart the 2011 PCI guideline antiplatelet therapy in patients with coronary artery disease:
Australian Clinical Guidelines for the antiplatelet and anti -thrombin PCI or CABG • GRACE score >109 and <140
In patients with AF, adjusted-dose warfarin and antiplatelet agents reduce the A post hoc analysis from the American Heart Association PCI guidelines,
Percutaneous coronary intervention (PCI) is not uncommon among patients on oral anticoagulation (OAC) for atrial fibrillation (AF). Yet it poses a conundrum between
The PIONEER AF-PCI compares rivaroxaban NOAC and Vitamin-K Antagonists for ACS, PCI in Atrial Fib: European Consensus Statement – Medscape Post as: processing
15/11/2016 · Gibson et al reports the results of the PIONEER AF-PCI trial. This trial was a randomized clinical trial of three antiplatelet Guidelines; Home
22/04/2016 · Coronary Artery Bypass Grafting (CABG) Guidelines [PCI] or coronary artery bypass grafting [CABG]). restart dual antiplatelet therapy when bleeding
Guideline for Anticoagulation and Prophylaxis Using Low (NOTE: In 2017, antiplatelet agents)
What are the Treatment Guidelines of Atrial Fibrillation Treatment Guidelines of Atrial Fibrillation (AFib or AF) What are the treatment guidelines for atrial
The guideline-directed addition of dual antiplatelet The PIONEER AF-PCI trial The authors concluded that in patients with atrial fibrillation post-PCI
Objective The aim of this systematic review and network meta-analysis was to evaluate (PCI) with dual-antiplatelet available for AF patients in post-PCI.
Anticoagulation strategies in patients with atrial fibrillation after PCI or and anticoagulation strategies in patients with AF post-PCI or post–ACS cohort
A 76-year-old woman with drug eluting stent placed post-STEMI will need an antiplatelet The Post-PCI Patient for atrial fibrillation (AF)
… including studies of patients with AF post-PCI. or possibly two antiplatelet agents. Until 2016 through 2017, Some of these guidelines were all
Patients with AF who undergo PCI with stenting The combination of dual antiplatelet therapy and RE-DUAL PCI sub-analysis data presented at AHA 2017;
YouTube Embed: No video/playlist ID has been supplied
Anticoagulant and Antiplatelet Therapy Use in Patients
NOACs in Patients Requiring Anticoagulation Post-PCI
Anticoagulation and antiplatelet therapy in June 2016 and the 31st May 2017 at our University Hospital the patient had AF (7.5% of the total PCI
Early and sustained dual oral antiplatelet therapy Guidelines for the (XIENCE V Everolimus Eluting Coronary Stent System condition-of- approval post
Guidelines for the use of antiplatelet therapy in patients with therapy in patients with coronary dual antiplatelet therapy within 12 months of PCI
Dual Antiplatelet Therapy and Anticoagulation in Patients Post Percutaenous for AF and antiplatelet therapy post PCI the use of warfarin
Evidence-based recommendations on the acute management of myocardial infarction with ST-segment elevation (STEMI) in with follow-on primary PCI if indicated,
Australian Clinical Guidelines for the •combination antiplatelet and anti-thrombin therapy Primary PCI is preferred for reperfusion therapy in patients with
A Summary and Update on Combining Antiplatelet Agents and/or Oral Anticoagulants rivaroxaban in AF patients undergoing PCI. 13 pharmacotherapy post-PCI
2017 ESC focused update on dual antiplatelet PIONEER AF-PCI. An overview of recommendations endorsed by these guidelines regarding DAPT duration after PCI,
Recent systematic reviews and meta-analyses suggest that shorter durations of dual antiplatelet 12 guidelines recommend dual antiplatelet 2017. All rights
12/10/2016 · The goals of pharmacotherapy in percutaneous coronary intervention (PCI) [Guideline] Amsterdam EA, Parisi AF, Folland ED, Hartigan
An Update of the 2011 ACC/AHA/SCAI PCI Guideline, about the updated guideline on duration of dual antiplatelet American College of Cardiology
2017 ESC Focused update on Dual Antiplatelet Therapy (DAPT) As post-PCI bleeding is Access the ESC Clinical Practice Guidelines 2017 Focused update on Dual
Dr Deepak Bhatt previews the important data to be released at ESC Congress 2017. PIONEER AF-PCI compared guidelines recommend that patients with AF take OAC
Resources. The information Use of antiplatelet therapy in patients with coronary stents undergoing non (PCI) including Guidelines on the Performance of
Cardiology Grand Rounds: Dual Antiplatelet Therapy After PCI or ACS: How Long, Which Drugs and What Do the 2016 Guidelines Recommend? Presented by Gary Schaer, MD
New oral anticoagulants and perioperative management of management of anticoagulant/antiplatelet AF (P <0.001). The 30-day risk for post
Researchers from the RE-DUAL PCI trial assigned 2,725 patients with AF who underwent PCI to with AF needing antiplatelet therapy post-PCI. guidelines
ESC Committee for Practice Guidelines (2017) 00,1–8 ESC GUIDELINES STEMI patients who underwent primary PCI or fibrinolysis with sub-
Prolonged dual-antiplatelet therapy after PCI of dual-antiplatelet therapy post PCI with a drug guidelines on antithrombotic therapy for AF;
For years, the optimal management of triple antithrombotic therapy has been empirical, with expert consensus documents providing some sort of direction in a guideline
Clinical Question. Among patients with nonvalvular AF undergoing PCI with stent placement, does low-dose rivaroxaban plus either single or dual antiplatelet therapy
ESC GUIDELINES ESC Guidelines for coronary syndromes in patients presenting without persistent ST-segment elevation Antiplatelet agents
As post-PCI bleeding is independently associated with mortality, Access the ESC Clinical Practice Guidelines 2017 Focused update on Dual Antiplatelet Therapy
1/16/2017 1 Anticoagulation for Atrial Fibrillation: DOAC post PCI N EnglJ Med 2016;375 N = 2124 participants with AF undergoing PCI
Contemporary Antithrombotic Treatment in Patients with Non
Dual Antiplatelet Therapy and Anticoagulation in Patients Post Percutaenous anticoagulation for AF and antiplatelet therapy post PCI the use of warfarin and
The CCS 2016 AF Guidelines suggest using a DOAC in AF with PCI needs to be established. A post-hoc 2017– WWW.CA PIONEER AF-PCI
Management of Atrial Fibrillation: Complete Guidelines For patients with AF and recent elective PCI, adapted from CCS 2012 Antiplatelet Therapy Guidelines)
Request PDF on ResearchGate Anticoagulation strategies in patients with atrial fibrillation after PCI or with ACS Clinicians struggle daily with the optimal – python how to create moving north south east west … (AF): refer to local guidance as Guidelines on oral antiplatelet therapy in cardiovascular disease . PCI Patients Post-CABG 10
… in post-PCI patients with non-valvular AF. Guidelines for the management of AF al. 2017 ESC focused update on dual antiplatelet therapy in
2017 ESC focused update on dual antiplatelet therapy in coronary on post-PCI patients by these guidelines regarding DAPT duration after PCI,
… SPAIN — The European Society of Cardiology has issued a new “focused update” on its guidelines on dual antiplatelet Medscape – Sep 14, 2017 Post-PCI
Optimizing Antithrombotic Care in Patients With AtriaL fibrillatiON and The AF guidelines of With AtriaL fibrillatiON and Coronary stEnt
A Summary and Update on Combining Antiplatelet Agents and/or Oral Anticoagulants therapy and to recommend an appropriate duration of pharmacotherapy post-PCI.
Guidelines and tools Presentations NHFA/CSANZ ACS Guidelines 2016 Guidelines for the management of acute coronary syndromes.
Global Impact of the 2017 ACC/AHA Hypertension Guidelines; Benefits and risks of extended duration dual antiplatelet therapy after PCI Efficacy of post
After PCI with stents for AF, adding rivaroxaban vs warfarin to antiplatelet drugs reduced bleeding Shamir R. Mehta, MD, MSc, FRCPC, FACC
Goals of Antiplatelet Therapy Post PCI 爀愀琀攀猀屲-CCS guideline based on extrapolation from AF NOAC trials 2017 . Patient Education
Anticoagulation strategies in patients with atrial
Any perioperative ischemic complications should be managed first with guideline-directed medical therapy, and PCI post-PCI, perioperative (2017) Antiplatelet
Approximately 20–30% of patients with AF, who are continuously taking an oral anticoagulant to reduce their risk of AF-related stroke, have coexisting coronary
Several studies in 2016 and 2017 dealt with Anticoagulant and Antiplatelet Therapy in investigators randomized more than 2700 patients with AF and PCI to
31/12/2015 · Managing Antiplatelet Therapy and Anticoagulants in Patients guidelines for peri-procedural and post-procedural primary PCI and AF,
… including studies of patients with AF post-PCI. or possibly two antiplatelet agents. Until 2016 through 2017, RECOMMENDATIONS OF OTHERS — Guidelines
Managing Antiplatelet Therapy and Anticoagulants in
Prolonged dual-antiplatelet therapy after PCI challenged
Optimizing Antithrombotic Care in Patients With AtriaL
NOAC and VKA for ACS PCI in Atrial Fib European Guidance
Management of Antiplatelet and Anticoagulant Therapy in
ESC 2017 RE-DUAL PCI shows benefits for dabigatran The
Anticoagulant and Antiplatelet Therapy in Patients with
fanuc cnc programming manual for turning and machining centers – Anticoagulation Challenge The Post-PCI Patient Patient Care
PIONEER AF-PCI Trial Summary – RxFiles
RE-DUAL PCI Dabigatran plus P2Y12 inhibitor lowers
YouTube Embed: No video/playlist ID has been supplied
PIONEER AF-PCI Phoenix Cardiology
ESC 2017 RE-DUAL PCI shows benefits for dabigatran The
Dual Antiplatelet Therapy and Anticoagulation in Patients
A Report of the American College of Cardiology/American Heart the 2011 PCI guideline antiplatelet therapy in patients with coronary artery disease:
12/10/2016 · The goals of pharmacotherapy in percutaneous coronary intervention (PCI) [Guideline] Amsterdam EA, Parisi AF, Folland ED, Hartigan
As post-PCI bleeding is independently associated with mortality, Access the ESC Clinical Practice Guidelines 2017 Focused update on Dual Antiplatelet Therapy
2017 ESC focused update on dual antiplatelet PIONEER AF-PCI. An overview of recommendations endorsed by these guidelines regarding DAPT duration after PCI,
A Summary and Update on Combining Antiplatelet Agents and/or Oral Anticoagulants therapy and to recommend an appropriate duration of pharmacotherapy post-PCI.
New Treatment Guidelines in Atrial Fibrillation and Updates on NOACs AHA/ACC Guidelines on AF with AF undergoing PCI to minimize need for
Global Impact of the 2017 ACC/AHA Hypertension Guidelines; Benefits and risks of extended duration dual antiplatelet therapy after PCI Efficacy of post
The CCS 2016 AF Guidelines suggest using a DOAC in AF with PCI needs to be established. A post-hoc 2017– WWW.CA PIONEER AF-PCI
… (AF): refer to local guidance as Guidelines on oral antiplatelet therapy in cardiovascular disease . PCI Patients Post-CABG 10
Dual Antiplatelet Therapy and Anticoagulation in Patients Post Percutaenous for AF and antiplatelet therapy post PCI the use of warfarin
Prolonged dual-antiplatelet therapy after PCI of dual-antiplatelet therapy post PCI with a drug guidelines on antithrombotic therapy for AF;
Evidence-based recommendations on the acute management of myocardial infarction with ST-segment elevation (STEMI) in with follow-on primary PCI if indicated,
ESC Committee for Practice Guidelines (2017) 00,1–8 ESC GUIDELINES STEMI patients who underwent primary PCI or fibrinolysis with sub-
PIONEER AF-PCI Wiki Journal Club
Anticoagulation strategies in patients with atrial
… SPAIN — The European Society of Cardiology has issued a new “focused update” on its guidelines on dual antiplatelet Medscape – Sep 14, 2017 Post-PCI
15/11/2016 · Gibson et al reports the results of the PIONEER AF-PCI trial. This trial was a randomized clinical trial of three antiplatelet Guidelines; Home
Management of Atrial Fibrillation: Complete Guidelines For patients with AF and recent elective PCI, adapted from CCS 2012 Antiplatelet Therapy Guidelines)
Several studies in 2016 and 2017 dealt with Anticoagulant and Antiplatelet Therapy in investigators randomized more than 2700 patients with AF and PCI to
1/16/2017 1 Anticoagulation for Atrial Fibrillation: DOAC post PCI N EnglJ Med 2016;375 N = 2124 participants with AF undergoing PCI
… including studies of patients with AF post-PCI. or possibly two antiplatelet agents. Until 2016 through 2017, Some of these guidelines were all
Clinical Question. Among patients with nonvalvular AF undergoing PCI with stent placement, does low-dose rivaroxaban plus either single or dual antiplatelet therapy
What are the Treatment Guidelines of Atrial Fibrillation Treatment Guidelines of Atrial Fibrillation (AFib or AF) What are the treatment guidelines for atrial
Australian Clinical Guidelines for the antiplatelet and anti -thrombin PCI or CABG • GRACE score >109 and <140
Goals of Antiplatelet Therapy Post PCI 爀愀琀攀猀屲-CCS guideline based on extrapolation from AF NOAC trials 2017 . Patient Education
Guideline for Anticoagulation and Prophylaxis Using Low (NOTE: In 2017, antiplatelet agents)
Contemporary Antithrombotic Treatment in Patients with Non
PIONEER AF-PCI Trial Summary – RxFiles
For years, the optimal management of triple antithrombotic therapy has been empirical, with expert consensus documents providing some sort of direction in a guideline
In patients with AF, adjusted-dose warfarin and antiplatelet agents reduce the A post hoc analysis from the American Heart Association PCI guidelines,
… (AF): refer to local guidance as Guidelines on oral antiplatelet therapy in cardiovascular disease . PCI Patients Post-CABG 10
1/16/2017 1 Anticoagulation for Atrial Fibrillation: DOAC post PCI N EnglJ Med 2016;375 N = 2124 participants with AF undergoing PCI
Objective The aim of this systematic review and network meta-analysis was to evaluate (PCI) with dual-antiplatelet available for AF patients in post-PCI.
Several studies in 2016 and 2017 dealt with Anticoagulant and Antiplatelet Therapy in investigators randomized more than 2700 patients with AF and PCI to
A Summary and Update on Combining Antiplatelet Agents and/or Oral Anticoagulants rivaroxaban in AF patients undergoing PCI. 13 pharmacotherapy post-PCI
Early and sustained dual oral antiplatelet therapy Guidelines for the (XIENCE V Everolimus Eluting Coronary Stent System condition-of- approval post
Anticoagulation strategies in patients with atrial fibrillation after PCI or and anticoagulation strategies in patients with AF post-PCI or post–ACS cohort
Anticoagulation and antiplatelet therapy in June 2016 and the 31st May 2017 at our University Hospital the patient had AF (7.5% of the total PCI
Guideline for Anticoagulation and Prophylaxis Using Low (NOTE: In 2017, antiplatelet agents)
Prolonged dual-antiplatelet therapy after PCI challenged
ESC 2017 RE-DUAL PCI shows benefits for dabigatran The
Researchers from the RE-DUAL PCI trial assigned 2,725 patients with AF who underwent PCI to with AF needing antiplatelet therapy post-PCI. guidelines
In patients with AF, adjusted-dose warfarin and antiplatelet agents reduce the A post hoc analysis from the American Heart Association PCI guidelines,
31/12/2015 · Managing Antiplatelet Therapy and Anticoagulants in Patients guidelines for peri-procedural and post-procedural primary PCI and AF,
Any perioperative ischemic complications should be managed first with guideline-directed medical therapy, and PCI post-PCI, perioperative (2017) Antiplatelet
Goals of Antiplatelet Therapy Post PCI 爀愀琀攀猀屲-CCS guideline based on extrapolation from AF NOAC trials 2017 . Patient Education
ESC Committee for Practice Guidelines (2017) 00,1–8 ESC GUIDELINES STEMI patients who underwent primary PCI or fibrinolysis with sub-
Global Impact of the 2017 ACC/AHA Hypertension Guidelines; Benefits and risks of extended duration dual antiplatelet therapy after PCI Efficacy of post
… (AF): refer to local guidance as Guidelines on oral antiplatelet therapy in cardiovascular disease . PCI Patients Post-CABG 10
Recent systematic reviews and meta-analyses suggest that shorter durations of dual antiplatelet 12 guidelines recommend dual antiplatelet 2017. All rights
… SPAIN — The European Society of Cardiology has issued a new “focused update” on its guidelines on dual antiplatelet Medscape – Sep 14, 2017 Post-PCI
Percutaneous coronary intervention (PCI) is not uncommon among patients on oral anticoagulation (OAC) for atrial fibrillation (AF). Yet it poses a conundrum between
Australian Clinical Guidelines for the •combination antiplatelet and anti-thrombin therapy Primary PCI is preferred for reperfusion therapy in patients with
Resources. The information Use of antiplatelet therapy in patients with coronary stents undergoing non (PCI) including Guidelines on the Performance of
Updates in Anticoagulation Key Sessions at ESC 2017
Anticoagulant and Antiplatelet Therapy Use in Patients
Guidelines and tools Presentations NHFA/CSANZ ACS Guidelines 2016 Guidelines for the management of acute coronary syndromes.
… while 6 patients (17.1%) were receiving no anticoagulants/antiplatelets. various post-PCI strategies in patients with AF, guidelines on AF
New Treatment Guidelines in Atrial Fibrillation and Updates on NOACs AHA/ACC Guidelines on AF with AF undergoing PCI to minimize need for
Cardiology Grand Rounds: Dual Antiplatelet Therapy After PCI or ACS: How Long, Which Drugs and What Do the 2016 Guidelines Recommend? Presented by Gary Schaer, MD
A Summary and Update on Combining Antiplatelet Agents and/or Oral Anticoagulants rivaroxaban in AF patients undergoing PCI. 13 pharmacotherapy post-PCI
Prolonged dual-antiplatelet therapy after PCI of dual-antiplatelet therapy post PCI with a drug guidelines on antithrombotic therapy for AF;
ESC GUIDELINES ESC Guidelines for coronary syndromes in patients presenting without persistent ST-segment elevation Antiplatelet agents
2017 ESC focused update on dual antiplatelet PIONEER AF-PCI. An overview of recommendations endorsed by these guidelines regarding DAPT duration after PCI,
Goals of Antiplatelet Therapy Post PCI 爀愀琀攀猀屲-CCS guideline based on extrapolation from AF NOAC trials 2017 . Patient Education
Contemporary Antithrombotic Treatment in Patients with Non
RE-DUAL PCI Dabigatran plus P2Y12 inhibitor lowers
ESC Committee for Practice Guidelines (2017) 00,1–8 ESC GUIDELINES STEMI patients who underwent primary PCI or fibrinolysis with sub-
A Summary and Update on Combining Antiplatelet Agents and/or Oral Anticoagulants therapy and to recommend an appropriate duration of pharmacotherapy post-PCI.
The guideline-directed addition of dual antiplatelet The PIONEER AF-PCI trial The authors concluded that in patients with atrial fibrillation post-PCI
Approximately 20–30% of patients with AF, who are continuously taking an oral anticoagulant to reduce their risk of AF-related stroke, have coexisting coronary
Evidence-based recommendations on the acute management of myocardial infarction with ST-segment elevation (STEMI) in with follow-on primary PCI if indicated,
15/11/2016 · Gibson et al reports the results of the PIONEER AF-PCI trial. This trial was a randomized clinical trial of three antiplatelet Guidelines; Home
RE-DUAL PCI Dabigatran plus P2Y12 inhibitor lowers
Management of Antiplatelet and Anticoagulant Therapy in
Anticoagulation and antiplatelet therapy in June 2016 and the 31st May 2017 at our University Hospital the patient had AF (7.5% of the total PCI
… including studies of patients with AF post-PCI. or possibly two antiplatelet agents. Until 2016 through 2017, Some of these guidelines were all
An Update of the 2011 ACC/AHA/SCAI PCI Guideline, about the updated guideline on duration of dual antiplatelet American College of Cardiology
ESC Committee for Practice Guidelines (2017) 00,1–8 ESC GUIDELINES STEMI patients who underwent primary PCI or fibrinolysis with sub-
Goals of Antiplatelet Therapy Post PCI 爀愀琀攀猀屲-CCS guideline based on extrapolation from AF NOAC trials 2017 . Patient Education
Guidelines and tools Presentations NHFA/CSANZ ACS Guidelines 2016 Guidelines for the management of acute coronary syndromes.
Early and sustained dual oral antiplatelet therapy Guidelines for the (XIENCE V Everolimus Eluting Coronary Stent System condition-of- approval post
ESC GUIDELINES ESC Guidelines for coronary syndromes in patients presenting without persistent ST-segment elevation Antiplatelet agents
Global Impact of the 2017 ACC/AHA Hypertension Guidelines; Benefits and risks of extended duration dual antiplatelet therapy after PCI Efficacy of post
Dual Antiplatelet Therapy and Anticoagulation in Patients Post Percutaenous anticoagulation for AF and antiplatelet therapy post PCI the use of warfarin and
15/11/2016 · Gibson et al reports the results of the PIONEER AF-PCI trial. This trial was a randomized clinical trial of three antiplatelet Guidelines; Home
Anticoagulant and Antiplatelet Therapy Use in Patients
RE-DUAL PCI Dabigatran plus P2Y12 inhibitor lowers
The guideline-directed addition of dual antiplatelet The PIONEER AF-PCI trial The authors concluded that in patients with atrial fibrillation post-PCI
An Update of the 2011 ACC/AHA/SCAI PCI Guideline, about the updated guideline on duration of dual antiplatelet American College of Cardiology
A Report of the American College of Cardiology/American Heart the 2011 PCI guideline antiplatelet therapy in patients with coronary artery disease:
12/10/2016 · The goals of pharmacotherapy in percutaneous coronary intervention (PCI) [Guideline] Amsterdam EA, Parisi AF, Folland ED, Hartigan
Dual Antiplatelet Therapy and Anticoagulation in Patients Post Percutaenous anticoagulation for AF and antiplatelet therapy post PCI the use of warfarin and
… (AF): refer to local guidance as Guidelines on oral antiplatelet therapy in cardiovascular disease . PCI Patients Post-CABG 10
Optimizing Antithrombotic Care in Patients With AtriaL fibrillatiON and The AF guidelines of With AtriaL fibrillatiON and Coronary stEnt
Early and sustained dual oral antiplatelet therapy Guidelines for the (XIENCE V Everolimus Eluting Coronary Stent System condition-of- approval post
2017 ESC focused update on dual antiplatelet PIONEER AF-PCI. An overview of recommendations endorsed by these guidelines regarding DAPT duration after PCI,
Anticoagulation and antiplatelet therapy in patients with
Dual Antiplatelet Therapy and Anticoagulation in Patients
31/12/2015 · Managing Antiplatelet Therapy and Anticoagulants in Patients guidelines for peri-procedural and post-procedural primary PCI and AF,
… (AF): refer to local guidance as Guidelines on oral antiplatelet therapy in cardiovascular disease . PCI Patients Post-CABG 10
Prolonged dual-antiplatelet therapy after PCI of dual-antiplatelet therapy post PCI with a drug guidelines on antithrombotic therapy for AF;
Request PDF on ResearchGate Anticoagulation strategies in patients with atrial fibrillation after PCI or with ACS Clinicians struggle daily with the optimal
Recent systematic reviews and meta-analyses suggest that shorter durations of dual antiplatelet 12 guidelines recommend dual antiplatelet 2017. All rights
As post-PCI bleeding is independently associated with mortality, Access the ESC Clinical Practice Guidelines 2017 Focused update on Dual Antiplatelet Therapy
Guideline for Anticoagulation and Prophylaxis Using Low (NOTE: In 2017, antiplatelet agents)
12/10/2016 · The goals of pharmacotherapy in percutaneous coronary intervention (PCI) [Guideline] Amsterdam EA, Parisi AF, Folland ED, Hartigan
The guideline-directed addition of dual antiplatelet The PIONEER AF-PCI trial The authors concluded that in patients with atrial fibrillation post-PCI
Guidelines and tools Presentations NHFA/CSANZ ACS Guidelines 2016 Guidelines for the management of acute coronary syndromes.
A Report of the American College of Cardiology/American Heart the 2011 PCI guideline antiplatelet therapy in patients with coronary artery disease:
New Treatment Guidelines in Atrial Fibrillation and Updates on NOACs AHA/ACC Guidelines on AF with AF undergoing PCI to minimize need for
RE-DUAL PCI™ sub-analysis data presented at AHA 2017 Press
Dual Antiplatelet Therapy After PCI or ACS VuMedi
Anticoagulation and antiplatelet therapy in June 2016 and the 31st May 2017 at our University Hospital the patient had AF (7.5% of the total PCI
15/11/2016 · Gibson et al reports the results of the PIONEER AF-PCI trial. This trial was a randomized clinical trial of three antiplatelet Guidelines; Home
A Summary and Update on Combining Antiplatelet Agents and/or Oral Anticoagulants therapy and to recommend an appropriate duration of pharmacotherapy post-PCI.
… including studies of patients with AF post-PCI. or possibly two antiplatelet agents. Until 2016 through 2017, RECOMMENDATIONS OF OTHERS — Guidelines
A 76-year-old woman with drug eluting stent placed post-STEMI will need an antiplatelet The Post-PCI Patient for atrial fibrillation (AF)
The use of UpToDate et al. Benefits and Risks of Extended Duration Dual Antiplatelet Therapy After PCI A Systematic Review for the 2016 ACC/AHA Guideline
2017 ESC focused update on dual antiplatelet therapy in coronary on post-PCI patients by these guidelines regarding DAPT duration after PCI,
An Update of the 2011 ACC/AHA/SCAI PCI Guideline, about the updated guideline on duration of dual antiplatelet American College of Cardiology
PIONEER AF-PCI Phoenix Cardiology
NOAC and VKA for ACS PCI in Atrial Fib European Guidance
Dual Antiplatelet Therapy and Anticoagulation in Patients Post Percutaenous for AF and antiplatelet therapy post PCI the use of warfarin
15/11/2016 · Gibson et al reports the results of the PIONEER AF-PCI trial. This trial was a randomized clinical trial of three antiplatelet Guidelines; Home
An Update of the 2011 ACC/AHA/SCAI PCI Guideline, about the updated guideline on duration of dual antiplatelet American College of Cardiology
Prolonged dual-antiplatelet therapy after PCI of dual-antiplatelet therapy post PCI with a drug guidelines on antithrombotic therapy for AF;
Approximately 20–30% of patients with AF, who are continuously taking an oral anticoagulant to reduce their risk of AF-related stroke, have coexisting coronary
Contemporary Antithrombotic Treatment in Patients with Non
Antithrombotic therapy strategies for atrial fibrillation
Several studies in 2016 and 2017 dealt with Anticoagulant and Antiplatelet Therapy in investigators randomized more than 2700 patients with AF and PCI to
2017 ESC focused update on dual antiplatelet PIONEER AF-PCI. An overview of recommendations endorsed by these guidelines regarding DAPT duration after PCI,
22/04/2016 · Coronary Artery Bypass Grafting (CABG) Guidelines [PCI] or coronary artery bypass grafting [CABG]). restart dual antiplatelet therapy when bleeding
Dual Antiplatelet Therapy and Anticoagulation in Patients Post Percutaenous for AF and antiplatelet therapy post PCI the use of warfarin
Objective The aim of this systematic review and network meta-analysis was to evaluate (PCI) with dual-antiplatelet available for AF patients in post-PCI.
Optimizing Antithrombotic Care in Patients With AtriaL fibrillatiON and The AF guidelines of With AtriaL fibrillatiON and Coronary stEnt
The PIONEER AF-PCI compares rivaroxaban NOAC and Vitamin-K Antagonists for ACS, PCI in Atrial Fib: European Consensus Statement – Medscape Post as: processing
Guidelines for the use of antiplatelet therapy in patients with therapy in patients with coronary dual antiplatelet therapy within 12 months of PCI
As post-PCI bleeding is independently associated with mortality, Access the ESC Clinical Practice Guidelines 2017 Focused update on Dual Antiplatelet Therapy
Prolonged dual-antiplatelet therapy after PCI of dual-antiplatelet therapy post PCI with a drug guidelines on antithrombotic therapy for AF;
For years, the optimal management of triple antithrombotic therapy has been empirical, with expert consensus documents providing some sort of direction in a guideline
… including studies of patients with AF post-PCI. or possibly two antiplatelet agents. Until 2016 through 2017, Some of these guidelines were all
… while 6 patients (17.1%) were receiving no anticoagulants/antiplatelets. various post-PCI strategies in patients with AF, guidelines on AF
In patients with AF, adjusted-dose warfarin and antiplatelet agents reduce the A post hoc analysis from the American Heart Association PCI guidelines,
Approximately 20–30% of patients with AF, who are continuously taking an oral anticoagulant to reduce their risk of AF-related stroke, have coexisting coronary
NOACs in Patients Requiring Anticoagulation Post-PCI
Dual Antiplatelet Therapy and Anticoagulation in Patients
Global Impact of the 2017 ACC/AHA Hypertension Guidelines; Benefits and risks of extended duration dual antiplatelet therapy after PCI Efficacy of post
Guideline for Anticoagulation and Prophylaxis Using Low (NOTE: In 2017, antiplatelet agents)
Clinical Question. Among patients with nonvalvular AF undergoing PCI with stent placement, does low-dose rivaroxaban plus either single or dual antiplatelet therapy
2017 ESC focused update on dual antiplatelet PIONEER AF-PCI. An overview of recommendations endorsed by these guidelines regarding DAPT duration after PCI,
… SPAIN — The European Society of Cardiology has issued a new “focused update” on its guidelines on dual antiplatelet Medscape – Sep 14, 2017 Post-PCI
Guidelines and tools Presentations NHFA/CSANZ ACS Guidelines 2016 Guidelines for the management of acute coronary syndromes.
2017 ESC Focused update on Dual Antiplatelet Therapy (DAPT) As post-PCI bleeding is Access the ESC Clinical Practice Guidelines 2017 Focused update on Dual
1/16/2017 1 Anticoagulation for Atrial Fibrillation: DOAC post PCI N EnglJ Med 2016;375 N = 2124 participants with AF undergoing PCI
Researchers from the RE-DUAL PCI trial assigned 2,725 patients with AF who underwent PCI to with AF needing antiplatelet therapy post-PCI. guidelines
A Report of the American College of Cardiology/American Heart the 2011 PCI guideline antiplatelet therapy in patients with coronary artery disease:
For years, the optimal management of triple antithrombotic therapy has been empirical, with expert consensus documents providing some sort of direction in a guideline
Objective The aim of this systematic review and network meta-analysis was to evaluate (PCI) with dual-antiplatelet available for AF patients in post-PCI.
ESC GUIDELINES ESC Guidelines for coronary syndromes in patients presenting without persistent ST-segment elevation Antiplatelet agents
PIONEER AF-PCI Wiki Journal Club
RE-DUAL PCI™ sub-analysis data presented at AHA 2017 Press
Goals of Antiplatelet Therapy Post PCI 爀愀琀攀猀屲-CCS guideline based on extrapolation from AF NOAC trials 2017 . Patient Education
A Summary and Update on Combining Antiplatelet Agents and/or Oral Anticoagulants therapy and to recommend an appropriate duration of pharmacotherapy post-PCI.
… in post-PCI patients with non-valvular AF. Guidelines for the management of AF al. 2017 ESC focused update on dual antiplatelet therapy in
22/04/2016 · Coronary Artery Bypass Grafting (CABG) Guidelines [PCI] or coronary artery bypass grafting [CABG]). restart dual antiplatelet therapy when bleeding
A Report of the American College of Cardiology/American Heart the 2011 PCI guideline antiplatelet therapy in patients with coronary artery disease:
After PCI with stents for AF, adding rivaroxaban vs warfarin to antiplatelet drugs reduced bleeding Shamir R. Mehta, MD, MSc, FRCPC, FACC
Dual Antiplatelet Therapy and Anticoagulation in Patients Post Percutaenous for AF and antiplatelet therapy post PCI the use of warfarin
Guidelines for the use of antiplatelet therapy in patients with therapy in patients with coronary dual antiplatelet therapy within 12 months of PCI
New Treatment Guidelines in Atrial Fibrillation and Updates on NOACs AHA/ACC Guidelines on AF with AF undergoing PCI to minimize need for
The CCS 2016 AF Guidelines suggest using a DOAC in AF with PCI needs to be established. A post-hoc 2017– WWW.CA PIONEER AF-PCI
… including studies of patients with AF post-PCI. or possibly two antiplatelet agents. Until 2016 through 2017, Some of these guidelines were all
12/10/2016 · The goals of pharmacotherapy in percutaneous coronary intervention (PCI) [Guideline] Amsterdam EA, Parisi AF, Folland ED, Hartigan
Anticoagulation and antiplatelet therapy in June 2016 and the 31st May 2017 at our University Hospital the patient had AF (7.5% of the total PCI
What are the Treatment Guidelines of Atrial Fibrillation Treatment Guidelines of Atrial Fibrillation (AFib or AF) What are the treatment guidelines for atrial
PIONEER AF-PCI Trial Summary – RxFiles
Management of Antiplatelet and Anticoagulant Therapy in
The guideline-directed addition of dual antiplatelet The PIONEER AF-PCI trial The authors concluded that in patients with atrial fibrillation post-PCI
ESC Committee for Practice Guidelines (2017) 00,1–8 ESC GUIDELINES STEMI patients who underwent primary PCI or fibrinolysis with sub-
Guidelines and tools Presentations NHFA/CSANZ ACS Guidelines 2016 Guidelines for the management of acute coronary syndromes.
Dual Antiplatelet Therapy and Anticoagulation in Patients Post Percutaenous for AF and antiplatelet therapy post PCI the use of warfarin
A 76-year-old woman with drug eluting stent placed post-STEMI will need an antiplatelet The Post-PCI Patient for atrial fibrillation (AF)
Anticoagulation strategies in patients with atrial fibrillation after PCI or and anticoagulation strategies in patients with AF post-PCI or post–ACS cohort
Dual Antiplatelet Therapy and Anticoagulation in Patients Post Percutaenous anticoagulation for AF and antiplatelet therapy post PCI the use of warfarin and
… in post-PCI patients with non-valvular AF. Guidelines for the management of AF al. 2017 ESC focused update on dual antiplatelet therapy in
Prolonged dual-antiplatelet therapy after PCI of dual-antiplatelet therapy post PCI with a drug guidelines on antithrombotic therapy for AF;
A Summary and Update on Combining Antiplatelet Agents and/or Oral Anticoagulants rivaroxaban in AF patients undergoing PCI. 13 pharmacotherapy post-PCI
Dual Antiplatelet Therapy and Anticoagulation in Patients
NOACs in Patients Requiring Anticoagulation Post-PCI
Dual Antiplatelet Therapy and Anticoagulation in Patients Post Percutaenous for AF and antiplatelet therapy post PCI the use of warfarin
2017 ESC Focused update on Dual Antiplatelet Therapy (DAPT) As post-PCI bleeding is Access the ESC Clinical Practice Guidelines 2017 Focused update on Dual
… in post-PCI patients with non-valvular AF. Guidelines for the management of AF al. 2017 ESC focused update on dual antiplatelet therapy in
New oral anticoagulants and perioperative management of management of anticoagulant/antiplatelet AF (P <0.001). The 30-day risk for post
The use of UpToDate et al. Benefits and Risks of Extended Duration Dual Antiplatelet Therapy After PCI A Systematic Review for the 2016 ACC/AHA Guideline
12/10/2016 · The goals of pharmacotherapy in percutaneous coronary intervention (PCI) [Guideline] Amsterdam EA, Parisi AF, Folland ED, Hartigan
After PCI with stents for AF, adding rivaroxaban vs warfarin to antiplatelet drugs reduced bleeding Shamir R. Mehta, MD, MSc, FRCPC, FACC
Anticoagulation strategies in patients with atrial
Dual Antiplatelet Therapy After PCI or ACS VuMedi
A Summary and Update on Combining Antiplatelet Agents and/or Oral Anticoagulants rivaroxaban in AF patients undergoing PCI. 13 pharmacotherapy post-PCI
… including studies of patients with AF post-PCI. or possibly two antiplatelet agents. Until 2016 through 2017, RECOMMENDATIONS OF OTHERS — Guidelines
An Update of the 2011 ACC/AHA/SCAI PCI Guideline, about the updated guideline on duration of dual antiplatelet American College of Cardiology
A Report of the American College of Cardiology/American Heart the 2011 PCI guideline antiplatelet therapy in patients with coronary artery disease:
12/10/2016 · The goals of pharmacotherapy in percutaneous coronary intervention (PCI) [Guideline] Amsterdam EA, Parisi AF, Folland ED, Hartigan
Dual Antiplatelet Therapy and Anticoagulation in Patients Post Percutaenous anticoagulation for AF and antiplatelet therapy post PCI the use of warfarin and
In patients with AF, adjusted-dose warfarin and antiplatelet agents reduce the A post hoc analysis from the American Heart Association PCI guidelines,
Resources. The information Use of antiplatelet therapy in patients with coronary stents undergoing non (PCI) including Guidelines on the Performance of
Percutaneous coronary intervention (PCI) is not uncommon among patients on oral anticoagulation (OAC) for atrial fibrillation (AF). Yet it poses a conundrum between
Guidelines and tools Presentations NHFA/CSANZ ACS Guidelines 2016 Guidelines for the management of acute coronary syndromes.
Global Impact of the 2017 ACC/AHA Hypertension Guidelines; Benefits and risks of extended duration dual antiplatelet therapy after PCI Efficacy of post
Updates in Anticoagulation Key Sessions at ESC 2017
Dual Antiplatelet Therapy After PCI or ACS VuMedi
Global Impact of the 2017 ACC/AHA Hypertension Guidelines; Benefits and risks of extended duration dual antiplatelet therapy after PCI Efficacy of post
For years, the optimal management of triple antithrombotic therapy has been empirical, with expert consensus documents providing some sort of direction in a guideline
Request PDF on ResearchGate Anticoagulation strategies in patients with atrial fibrillation after PCI or with ACS Clinicians struggle daily with the optimal
1/16/2017 1 Anticoagulation for Atrial Fibrillation: DOAC post PCI N EnglJ Med 2016;375 N = 2124 participants with AF undergoing PCI
Optimizing Antithrombotic Care in Patients With AtriaL fibrillatiON and The AF guidelines of With AtriaL fibrillatiON and Coronary stEnt
ESC Committee for Practice Guidelines (2017) 00,1–8 ESC GUIDELINES STEMI patients who underwent primary PCI or fibrinolysis with sub-
Anticoagulation and antiplatelet therapy in June 2016 and the 31st May 2017 at our University Hospital the patient had AF (7.5% of the total PCI
A Summary and Update on Combining Antiplatelet Agents and/or Oral Anticoagulants rivaroxaban in AF patients undergoing PCI. 13 pharmacotherapy post-PCI
As post-PCI bleeding is independently associated with mortality, Access the ESC Clinical Practice Guidelines 2017 Focused update on Dual Antiplatelet Therapy
The use of UpToDate et al. Benefits and Risks of Extended Duration Dual Antiplatelet Therapy After PCI A Systematic Review for the 2016 ACC/AHA Guideline
PIONEER AF-PCI Wiki Journal Club
Contemporary Antithrombotic Treatment in Patients with Non
ESC Committee for Practice Guidelines (2017) 00,1–8 ESC GUIDELINES STEMI patients who underwent primary PCI or fibrinolysis with sub-
… including studies of patients with AF post-PCI. or possibly two antiplatelet agents. Until 2016 through 2017, Some of these guidelines were all
22/04/2016 · Coronary Artery Bypass Grafting (CABG) Guidelines [PCI] or coronary artery bypass grafting [CABG]). restart dual antiplatelet therapy when bleeding
31/12/2015 · Managing Antiplatelet Therapy and Anticoagulants in Patients guidelines for peri-procedural and post-procedural primary PCI and AF,
Dual Antiplatelet Therapy and Anticoagulation in Patients Post Percutaenous anticoagulation for AF and antiplatelet therapy post PCI the use of warfarin and
After PCI with stents for AF, adding rivaroxaban vs warfarin to antiplatelet drugs reduced bleeding Shamir R. Mehta, MD, MSc, FRCPC, FACC
The use of UpToDate et al. Benefits and Risks of Extended Duration Dual Antiplatelet Therapy After PCI A Systematic Review for the 2016 ACC/AHA Guideline
… in post-PCI patients with non-valvular AF. Guidelines for the management of AF al. 2017 ESC focused update on dual antiplatelet therapy in
… SPAIN — The European Society of Cardiology has issued a new “focused update” on its guidelines on dual antiplatelet Medscape – Sep 14, 2017 Post-PCI
Patients with AF who undergo PCI with stenting The combination of dual antiplatelet therapy and RE-DUAL PCI sub-analysis data presented at AHA 2017;
As post-PCI bleeding is independently associated with mortality, Access the ESC Clinical Practice Guidelines 2017 Focused update on Dual Antiplatelet Therapy
What are the Treatment Guidelines of Atrial Fibrillation Treatment Guidelines of Atrial Fibrillation (AFib or AF) What are the treatment guidelines for atrial
… while 6 patients (17.1%) were receiving no anticoagulants/antiplatelets. various post-PCI strategies in patients with AF, guidelines on AF
In patients with AF, adjusted-dose warfarin and antiplatelet agents reduce the A post hoc analysis from the American Heart Association PCI guidelines,
Management of Atrial Fibrillation: Complete Guidelines For patients with AF and recent elective PCI, adapted from CCS 2012 Antiplatelet Therapy Guidelines)
Management of Antiplatelet and Anticoagulant Therapy in
22/04/2016 · Coronary Artery Bypass Grafting (CABG) Guidelines [PCI] or coronary artery bypass grafting [CABG]). restart dual antiplatelet therapy when bleeding
Anticoagulation strategies in patients with atrial
Anticoagulant and Antiplatelet Therapy in Patients with
A Report of the American College of Cardiology/American Heart the 2011 PCI guideline antiplatelet therapy in patients with coronary artery disease:
Anticoagulant and Antiplatelet Therapy in Patients with
Dual Antiplatelet Therapy and Anticoagulation in Patients Post Percutaenous anticoagulation for AF and antiplatelet therapy post PCI the use of warfarin and
Anticoagulant and Antiplatelet Therapy Use in Patients
Australian Clinical Guidelines for the •combination antiplatelet and anti-thrombin therapy Primary PCI is preferred for reperfusion therapy in patients with
Updates in Anticoagulation Key Sessions at ESC 2017
Global Impact of the 2017 ACC/AHA Hypertension Guidelines; Benefits and risks of extended duration dual antiplatelet therapy after PCI Efficacy of post
ESC 2017 RE-DUAL PCI shows benefits for dabigatran The
An Update of the 2011 ACC/AHA/SCAI PCI Guideline, about the updated guideline on duration of dual antiplatelet American College of Cardiology
RE-DUAL PCI Dabigatran plus P2Y12 inhibitor lowers
NOACs in Patients Requiring Anticoagulation Post-PCI
Anticoagulation Challenge The Post-PCI Patient Patient Care
Dr Deepak Bhatt previews the important data to be released at ESC Congress 2017. PIONEER AF-PCI compared guidelines recommend that patients with AF take OAC
Dual Antiplatelet Therapy and Anticoagulation in Patients
Researchers from the RE-DUAL PCI trial assigned 2,725 patients with AF who underwent PCI to with AF needing antiplatelet therapy post-PCI. guidelines
PIONEER AF-PCI Phoenix Cardiology
After PCI with stents for AF adding rivaroxaban vs
Global Impact of the 2017 ACC/AHA Hypertension Guidelines; Benefits and risks of extended duration dual antiplatelet therapy after PCI Efficacy of post
PIONEER AF-PCI Trial Summary – RxFiles
RE-DUAL PCI™ sub-analysis data presented at AHA 2017 Press
Updates in Anticoagulation Key Sessions at ESC 2017
New Treatment Guidelines in Atrial Fibrillation and Updates on NOACs AHA/ACC Guidelines on AF with AF undergoing PCI to minimize need for
PIONEER AF-PCI Wiki Journal Club
Updates in Anticoagulation Key Sessions at ESC 2017
NOACs in Patients Requiring Anticoagulation Post-PCI
What are the Treatment Guidelines of Atrial Fibrillation Treatment Guidelines of Atrial Fibrillation (AFib or AF) What are the treatment guidelines for atrial
Dual Antiplatelet Therapy After PCI or ACS VuMedi
… in post-PCI patients with non-valvular AF. Guidelines for the management of AF al. 2017 ESC focused update on dual antiplatelet therapy in
Anticoagulant and Antiplatelet Therapy Use in Patients
New Treatment Guidelines in Atrial Fibrillation and Updates on NOACs AHA/ACC Guidelines on AF with AF undergoing PCI to minimize need for
NOAC and VKA for ACS PCI in Atrial Fib European Guidance
Prolonged dual-antiplatelet therapy after PCI challenged
… in post-PCI patients with non-valvular AF. Guidelines for the management of AF al. 2017 ESC focused update on dual antiplatelet therapy in
Managing Antiplatelet Therapy and Anticoagulants in
… in post-PCI patients with non-valvular AF. Guidelines for the management of AF al. 2017 ESC focused update on dual antiplatelet therapy in
Dual Antiplatelet Therapy and Anticoagulation in Patients
Viewpoint a proposal for a simple algorithm for managing
The use of UpToDate et al. Benefits and Risks of Extended Duration Dual Antiplatelet Therapy After PCI A Systematic Review for the 2016 ACC/AHA Guideline
Management of Antiplatelet and Anticoagulant Therapy in
Managing Antiplatelet Therapy and Anticoagulants in
A Summary and Update on Combining Antiplatelet Agents and/or Oral Anticoagulants therapy and to recommend an appropriate duration of pharmacotherapy post-PCI.
Updates in Anticoagulation Key Sessions at ESC 2017
Dual Antiplatelet Therapy After PCI or ACS VuMedi
… SPAIN — The European Society of Cardiology has issued a new “focused update” on its guidelines on dual antiplatelet Medscape – Sep 14, 2017 Post-PCI
Prolonged dual-antiplatelet therapy after PCI challenged
Antithrombotic therapy strategies for atrial fibrillation
Cardiology Grand Rounds: Dual Antiplatelet Therapy After PCI or ACS: How Long, Which Drugs and What Do the 2016 Guidelines Recommend? Presented by Gary Schaer, MD
NOAC and VKA for ACS PCI in Atrial Fib European Guidance
Contemporary Antithrombotic Treatment in Patients with Non
Dual Antiplatelet Therapy and Anticoagulation in Patients
Recent systematic reviews and meta-analyses suggest that shorter durations of dual antiplatelet 12 guidelines recommend dual antiplatelet 2017. All rights
Dual Antiplatelet Therapy and Anticoagulation in Patients
Any perioperative ischemic complications should be managed first with guideline-directed medical therapy, and PCI post-PCI, perioperative (2017) Antiplatelet
Optimizing Antithrombotic Care in Patients With AtriaL
Anticoagulation strategies in patients with atrial fibrillation after PCI or and anticoagulation strategies in patients with AF post-PCI or post–ACS cohort
Antithrombotic therapy strategies for atrial fibrillation
Contemporary Antithrombotic Treatment in Patients with Non
ESC Committee for Practice Guidelines (2017) 00,1–8 ESC GUIDELINES STEMI patients who underwent primary PCI or fibrinolysis with sub-
Contemporary Antithrombotic Treatment in Patients with Non
Several studies in 2016 and 2017 dealt with Anticoagulant and Antiplatelet Therapy in investigators randomized more than 2700 patients with AF and PCI to
Antithrombotic therapy strategies for atrial fibrillation
The guideline-directed addition of dual antiplatelet The PIONEER AF-PCI trial The authors concluded that in patients with atrial fibrillation post-PCI
PIONEER AF-PCI Phoenix Cardiology
Updates in Anticoagulation Key Sessions at ESC 2017
RE-DUAL PCI™ sub-analysis data presented at AHA 2017 Press
1/16/2017 1 Anticoagulation for Atrial Fibrillation: DOAC post PCI N EnglJ Med 2016;375 N = 2124 participants with AF undergoing PCI
Contemporary Antithrombotic Treatment in Patients with Non
Anticoagulation and antiplatelet therapy in June 2016 and the 31st May 2017 at our University Hospital the patient had AF (7.5% of the total PCI
Triple antithrombotic therapy after ACS and PCI in
RE-DUAL PCI™ sub-analysis data presented at AHA 2017 Press
A Report of the American College of Cardiology/American Heart the 2011 PCI guideline antiplatelet therapy in patients with coronary artery disease:
Updates in Anticoagulation Key Sessions at ESC 2017
ESC 2017 RE-DUAL PCI shows benefits for dabigatran The
RE-DUAL PCI Dabigatran plus P2Y12 inhibitor lowers